Compare AMRX & KBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | KBH |
|---|---|---|
| Founded | 2002 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | N/A | 1987 |
| Metric | AMRX | KBH |
|---|---|---|
| Price | $11.98 | $61.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 13 |
| Target Price | $13.25 | ★ $67.17 |
| AVG Volume (30 Days) | ★ 1.7M | 782.1K |
| Earning Date | 10-30-2025 | 12-18-2025 |
| Dividend Yield | N/A | ★ 1.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.02 | ★ 7.17 |
| Revenue | $2,934,959,000.00 | ★ $6,541,735,000.00 |
| Revenue This Year | $9.99 | N/A |
| Revenue Next Year | $6.67 | N/A |
| P/E Ratio | $745.76 | ★ $8.60 |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $6.69 | $48.90 |
| 52 Week High | $12.68 | $79.79 |
| Indicator | AMRX | KBH |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 47.37 |
| Support Level | $11.83 | $63.52 |
| Resistance Level | $12.25 | $66.27 |
| Average True Range (ATR) | 0.33 | 1.77 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 44.31 | 47.47 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.